Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · IEX Real-Time Price · USD
11.50
-0.29 (-2.46%)
At close: Jul 26, 2024, 4:00 PM
11.30
-0.20 (-1.74%)
After-hours: Jul 26, 2024, 7:01 PM EDT
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $378.87 million as of July 26, 2024.
Market Cap
378.87M
Enterprise Value
191.80M
1-Year Change
n/a
Ranking
Category
Stock Price
$11.50
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $378.87M, an increase of 39.62%. That is a compound annual growth rate of 58.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 388.40M | 8.61% |
| Dec 29, 2023 | 357.60M | 31.78% |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alto Neuroscience | 406.49M |
| Kyverna Therapeutics | 405.71M |
| Esperion Therapeutics | 398.78M |
| Tourmaline Bio | 396.49M |
| uniQure | 390.09M |
| Q32 Bio | 386.45M |
| enGene Holdings | 383.36M |
| TScan Therapeutics | 382.20M |